Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Study protocol

Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania

Authors: Jillian L. Kadota, Laura J. Packel, Matilda Mlowe, Nzovu Ulenga, Natalino Mwenda, Prosper F. Njau, William H. Dow, Jingshen Wang, Amon Sabasaba, Sandra I. McCoy

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Economic incentives can improve clinical outcomes among in-care people living with HIV (PLHIV), but evidence is limited for their effectiveness among out-of-care PLHIV or those at risk of disengagement. We propose a type 1 hybrid effectiveness-implementation study to advance global knowledge about the use of economic incentives to strengthen the continuity of HIV care and accelerate global goals for HIV epidemic control.

Methods

The Rudi Kundini, Pamoja Kundini study will evaluate two implementation models of an economic incentive strategy for supporting two groups of PLHIV in Tanzania. Phase 1 of the study consists of a two-arm, cluster randomized trial across 32 health facilities to assess the effectiveness of a home visit plus one-time economic incentive on the proportion of out-of-care PLHIV with viral load suppression (< 1000 copies/ml) 6 months after enrollment (n = 640). Phase 2 is an individual 1:1 randomized controlled trial designed to determine the effectiveness of a short-term counseling and economic incentive program offered to in-care PLHIV who are predicted through machine learning to be at risk of disengaging from care on the outcome of viral load suppression at 12 months (n = 692). The program includes up to three incentives conditional upon visit attendance coupled with adapted counselling sessions for this population of PLHIV. Consistent with a hybrid effectiveness-implementation study design, phase 3 is a mixed methods evaluation to explore barriers and facilitators to strategy implementation in phases 1 and 2. Results will be used to guide optimization and scale-up of the incentive strategies, if effective, to the larger population of Tanzanian PLHIV who struggle with continuity of HIV care.

Discussion

Innovative strategies that recognize the dynamic process of lifelong retention in HIV care are urgently needed. Strategies such as conditional economic incentives are a simple and effective method for improving many health outcomes, including those on the HIV continuum. If coupled with other supportive services such as home visits (phase 1) or with tailored counselling (phase 2), economic incentives have the potential to strengthen engagement among the subpopulation of PLHIV who struggle with retention in care and could help to close the gap towards reaching global “95–95-95” goals for ending the AIDS epidemic.

Trial registration

Phase 1: ClinicalTrials.gov, NCT05248100, registered 2/21/2022.
Phase 2: ClinicalTrials.gov, NCT05373095, registered 5/13/2022.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fact Sheet - World AIDS Day 2021. UNAIDS; 2021. Fact Sheet - World AIDS Day 2021. UNAIDS; 2021.
2.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedPubMedCentralCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedPubMedCentralCrossRef
3.
go back to reference World Health Organization, Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. World Health Organization, Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.
4.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9.PubMedPubMedCentralCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016;375(9):830–9.PubMedPubMedCentralCrossRef
5.
go back to reference UNAIDS. Understanding Fast-Track: Accelerating Action to End the AIDS Epidemic by 2030. Geneva, Switzerland: UNAIDS; 2015. UNAIDS. Understanding Fast-Track: Accelerating Action to End the AIDS Epidemic by 2030. Geneva, Switzerland: UNAIDS; 2015.
6.
go back to reference UNAIDS Data 2021. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2021. UNAIDS Data 2021. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2021.
8.
go back to reference Bukenya D, Mayanja BN, Nakamanya S, Muhumuza R, Seeley J. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Res Ther. 2019;16(1):2.PubMedPubMedCentralCrossRef Bukenya D, Mayanja BN, Nakamanya S, Muhumuza R, Seeley J. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Res Ther. 2019;16(1):2.PubMedPubMedCentralCrossRef
10.
go back to reference Czaicki NL, Mnyippembe A, Blodgett M, Njau P, McCoy SI. It helps me live, sends my children to school, and feeds me: a qualitative study of how food and cash incentives may improve adherence to treatment and care among adults living with HIV in Tanzania. AIDS Care. 2017;7:876–84.CrossRef Czaicki NL, Mnyippembe A, Blodgett M, Njau P, McCoy SI. It helps me live, sends my children to school, and feeds me: a qualitative study of how food and cash incentives may improve adherence to treatment and care among adults living with HIV in Tanzania. AIDS Care. 2017;7:876–84.CrossRef
11.
go back to reference Czaicki NL, Dow WH, Njau PF, McCoy SI. Do incentives undermine intrinsic motivation? Increases in intrinsic motivation within an incentive-based intervention for people living with HIV in Tanzania. PLoS One. 2018;13(6):e0196616.PubMedPubMedCentralCrossRef Czaicki NL, Dow WH, Njau PF, McCoy SI. Do incentives undermine intrinsic motivation? Increases in intrinsic motivation within an incentive-based intervention for people living with HIV in Tanzania. PLoS One. 2018;13(6):e0196616.PubMedPubMedCentralCrossRef
12.
go back to reference Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;Suppl 5:S505-15.CrossRef Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;Suppl 5:S505-15.CrossRef
13.
go back to reference Singer AW, Weiser SD, McCoy SI. Does Food Insecurity Undermine Adherence to Antiretroviral Therapy? A Systematic Review AIDS Behav. 2015;8:1510–26.CrossRef Singer AW, Weiser SD, McCoy SI. Does Food Insecurity Undermine Adherence to Antiretroviral Therapy? A Systematic Review AIDS Behav. 2015;8:1510–26.CrossRef
14.
go back to reference Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 4 2013;10(1):e1001369; discussion e1001369. Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Med. 4 2013;10(1):e1001369; discussion e1001369.
15.
go back to reference Claborn KR, Meier E, Miller MB, Leffingwell TR. A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med. 2015;20(3):255–65.PubMedCrossRef Claborn KR, Meier E, Miller MB, Leffingwell TR. A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med. 2015;20(3):255–65.PubMedCrossRef
16.
go back to reference Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, et al. A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study. Lancet HIV. 2018;6:e301-8.CrossRef Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, et al. A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study. Lancet HIV. 2018;6:e301-8.CrossRef
17.
go back to reference Mugavero MJ. Elements of the HIV Care Continuum: Improving Engagement and Retention in Care. Top Antivir Med. 2016;24(3):115–9.PubMed Mugavero MJ. Elements of the HIV Care Continuum: Improving Engagement and Retention in Care. Top Antivir Med. 2016;24(3):115–9.PubMed
18.
go back to reference Geng EH, Holmes CB, Moshabela M, Sikazwe I, Petersen ML. Personalized public health: An implementation research agenda for the HIV response and beyond. PLoS Med. 2019;12:e1003020.CrossRef Geng EH, Holmes CB, Moshabela M, Sikazwe I, Petersen ML. Personalized public health: An implementation research agenda for the HIV response and beyond. PLoS Med. 2019;12:e1003020.CrossRef
20.
go back to reference Mody A, Eshun-Wilson I, Sikombe K, Schwartz SR, Beres LK, Simbeza S, et al. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis. PLoS Med. 2019;10:e1002959.CrossRef Mody A, Eshun-Wilson I, Sikombe K, Schwartz SR, Beres LK, Simbeza S, et al. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis. PLoS Med. 2019;10:e1002959.CrossRef
21.
go back to reference Czaicki NL, Holmes CB, Sikazwe I, Bolton C, Savory T, Wa Mwanza M, et al. Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics. AIDS. 2017;31(5):689–96.PubMedCrossRef Czaicki NL, Holmes CB, Sikazwe I, Bolton C, Savory T, Wa Mwanza M, et al. Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics. AIDS. 2017;31(5):689–96.PubMedCrossRef
22.
go back to reference Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, et al. Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019;1:e25218.CrossRef Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, et al. Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019;1:e25218.CrossRef
23.
go back to reference McCoy SI. Incentives and other behavioral economic approaches to bolster HIV prevention & care: State of the science. 24th International AIDS Conference AIDS 2022; Montreal, Canada. McCoy SI. Incentives and other behavioral economic approaches to bolster HIV prevention & care: State of the science. 24th International AIDS Conference AIDS 2022; Montreal, Canada.
24.
go back to reference Kelly N, Maokola W, Mudasiru O, McCoy SI. Interventions to Improve Linkage to HIV Care in the Era of “Treat All” in Sub-Saharan Africa: a Systematic Review. Curr HIV/AIDS Rep. 2019;4:292–303.CrossRef Kelly N, Maokola W, Mudasiru O, McCoy SI. Interventions to Improve Linkage to HIV Care in the Era of “Treat All” in Sub-Saharan Africa: a Systematic Review. Curr HIV/AIDS Rep. 2019;4:292–303.CrossRef
25.
go back to reference Galarraga O, Genberg BL, Martin RA, Barton Laws M, Wilson IB. Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations. AIDS Behav. 2013;7:2283–92.CrossRef Galarraga O, Genberg BL, Martin RA, Barton Laws M, Wilson IB. Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations. AIDS Behav. 2013;7:2283–92.CrossRef
26.
go back to reference Galarraga O, Sosa-Rubi SG. Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries. Lancet HIV. 2019;10:e705-14.CrossRef Galarraga O, Sosa-Rubi SG. Conditional economic incentives to improve HIV prevention and treatment in low-income and middle-income countries. Lancet HIV. 2019;10:e705-14.CrossRef
27.
go back to reference Talisuna-Alamo S, Colebunders R, Ouma J, Sunday P, Ekoru K, Laga M, et al. Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda. J Acquir Immune Defic Syndr. 2012;59(4):e52-9.PubMedCrossRef Talisuna-Alamo S, Colebunders R, Ouma J, Sunday P, Ekoru K, Laga M, et al. Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda. J Acquir Immune Defic Syndr. 2012;59(4):e52-9.PubMedCrossRef
28.
go back to reference Yotebieng M, Thirumurthy H, Moracco KE, Edmonds A, Tabala M, Kawende B, et al. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S124-9.PubMedPubMedCentralCrossRef Yotebieng M, Thirumurthy H, Moracco KE, Edmonds A, Tabala M, Kawende B, et al. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S124-9.PubMedPubMedCentralCrossRef
29.
go back to reference El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, et al. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065). JAMA Intern Med. 2017;177(8):1083–92.PubMedPubMedCentralCrossRef El-Sadr WM, Donnell D, Beauchamp G, Hall HI, Torian LV, Zingman B, et al. Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065). JAMA Intern Med. 2017;177(8):1083–92.PubMedPubMedCentralCrossRef
30.
go back to reference Thirumurthy H, Ndyabakira A, Marson K, Emperador D, Kamya M, Havlir D, et al. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. Lancet HIV. 2019;3:e155-63.CrossRef Thirumurthy H, Ndyabakira A, Marson K, Emperador D, Kamya M, Havlir D, et al. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. Lancet HIV. 2019;3:e155-63.CrossRef
31.
go back to reference Linnemayr S, Stecher C, Mukasa B. Behavioral economic incentives to improve adherence to antiretroviral medication. AIDS. 2017;31(5):719–26.PubMedCrossRef Linnemayr S, Stecher C, Mukasa B. Behavioral economic incentives to improve adherence to antiretroviral medication. AIDS. 2017;31(5):719–26.PubMedCrossRef
32.
go back to reference Solomon SS, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, Balakrishnan P, et al. Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai. India Clin Infect Dis. 2014;59(4):589–95.PubMedCrossRef Solomon SS, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, Balakrishnan P, et al. Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai. India Clin Infect Dis. 2014;59(4):589–95.PubMedCrossRef
33.
go back to reference McCoy SI, Njau PF, Fahey C, Kapologwe N, Kadiyala S, Jewell NP, et al. Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania. AIDS. 2017;31(6):815–25.PubMedCrossRef McCoy SI, Njau PF, Fahey C, Kapologwe N, Kadiyala S, Jewell NP, et al. Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania. AIDS. 2017;31(6):815–25.PubMedCrossRef
34.
go back to reference Roger A. Microeconomics. 13th edition. Mason, OH: Cengage; 2017. Roger A. Microeconomics. 13th edition. Mason, OH: Cengage; 2017.
35.
go back to reference Thaler RH, Sunstein CR. Nudge: Improving Decisions About Health, Wealth, and Happiness. New Haven: Yale University Press; 2008. Thaler RH, Sunstein CR. Nudge: Improving Decisions About Health, Wealth, and Happiness. New Haven: Yale University Press; 2008.
36.
go back to reference Deci EL, Ryan RM. Facilitating optimal motivation and psychological well-being across life’s domains. Canadian Psychology / Psychologie canadienne. 2008;49(1):14–23.CrossRef Deci EL, Ryan RM. Facilitating optimal motivation and psychological well-being across life’s domains. Canadian Psychology / Psychologie canadienne. 2008;49(1):14–23.CrossRef
37.
go back to reference Fahey CA, Njau PF, Katabaro E, Mfaume RS, Ulenga N, Mwenda N, et al. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. Lancet HIV. 2020;11:e762-71.CrossRef Fahey CA, Njau PF, Katabaro E, Mfaume RS, Ulenga N, Mwenda N, et al. Financial incentives to promote retention in care and viral suppression in adults with HIV initiating antiretroviral therapy in Tanzania: a three-arm randomised controlled trial. Lancet HIV. 2020;11:e762-71.CrossRef
38.
go back to reference Packel L, Fahey C, Njau P, McCoy SI. Implementation Science Using Proctor’s Framework and an Adaptation of the Multiphase Optimization Strategy: Optimizing a Financial Incentive Intervention for HIV Treatment Adherence in Tanzania. J Acquir Immune Defic Syndr. 2019;82(Suppl 3):S332–8.PubMedPubMedCentralCrossRef Packel L, Fahey C, Njau P, McCoy SI. Implementation Science Using Proctor’s Framework and an Adaptation of the Multiphase Optimization Strategy: Optimizing a Financial Incentive Intervention for HIV Treatment Adherence in Tanzania. J Acquir Immune Defic Syndr. 2019;82(Suppl 3):S332–8.PubMedPubMedCentralCrossRef
39.
go back to reference PEPFAR. Monitoring , Evaluation , and Reporting Indicator Reference Guide. 2019. PEPFAR. Monitoring , Evaluation , and Reporting Indicator Reference Guide. 2019.
40.
go back to reference National Guidelines for Home Based Care Services. National AIDS Control Programme (NACP); 2010. National Guidelines for Home Based Care Services. National AIDS Control Programme (NACP); 2010.
41.
go back to reference National Guidelines for the Management of HIV and AIDS. Dar es Salaam, Tanzania: National AIDS Control Programme; 2019. National Guidelines for the Management of HIV and AIDS. Dar es Salaam, Tanzania: National AIDS Control Programme; 2019.
42.
go back to reference Hémono R, Kelly NK, Fahey CA, Hassan K, Msasa J, Mfaume RS, et al. Financial incentives to improve re-engagement in HIV care: results from a randomized pilot study. AIDS Care. 2023;35(7):935–41.PubMedCrossRef Hémono R, Kelly NK, Fahey CA, Hassan K, Msasa J, Mfaume RS, et al. Financial incentives to improve re-engagement in HIV care: results from a randomized pilot study. AIDS Care. 2023;35(7):935–41.PubMedCrossRef
43.
go back to reference Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.PubMedPubMedCentralCrossRef Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.PubMedPubMedCentralCrossRef
44.
go back to reference Odeny TA, Padian N, Doherty MC, Baral S, Beyrer C, Ford N, et al. Definitions of implementation science in HIV/AIDS. Lancet HIV. 2015;2(5):e178-80.PubMedCrossRef Odeny TA, Padian N, Doherty MC, Baral S, Beyrer C, Ford N, et al. Definitions of implementation science in HIV/AIDS. Lancet HIV. 2015;2(5):e178-80.PubMedCrossRef
45.
go back to reference Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President’s Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56(3):199–203.PubMedCrossRef Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President’s Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56(3):199–203.PubMedCrossRef
46.
go back to reference Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Sci. 2009;4(1):50.CrossRef Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Sci. 2009;4(1):50.CrossRef
47.
go back to reference O’Donoghue T, Rabin M. Doing It Now or Later. American Economic Review. 1999;89(1):103–24.CrossRef O’Donoghue T, Rabin M. Doing It Now or Later. American Economic Review. 1999;89(1):103–24.CrossRef
48.
go back to reference Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415–7.PubMedCrossRef Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415–7.PubMedCrossRef
49.
go back to reference Loewenstein G, Chater N. Putting nudges in perspective. Behav Public Policy. 2017;1(1):26–53.CrossRef Loewenstein G, Chater N. Putting nudges in perspective. Behav Public Policy. 2017;1(1):26–53.CrossRef
50.
go back to reference Acland D, Levy MR. Naiveté, Projection Bias, and Habit Formation in Gym Attendance. Manage Sci. 2015;61(1):146–60.CrossRef Acland D, Levy MR. Naiveté, Projection Bias, and Habit Formation in Gym Attendance. Manage Sci. 2015;61(1):146–60.CrossRef
51.
go back to reference Gardner B. A review and analysis of the use of ‘habit’ in understanding, predicting and influencing health-related behaviour. Health Psychol Rev. 2015;9(3):277–95.PubMedCrossRef Gardner B. A review and analysis of the use of ‘habit’ in understanding, predicting and influencing health-related behaviour. Health Psychol Rev. 2015;9(3):277–95.PubMedCrossRef
52.
go back to reference Moulton LH. Covariate-based constrained randomization of group-randomized trials. Clin Trials. 2004;1(3):297–305.PubMedCrossRef Moulton LH. Covariate-based constrained randomization of group-randomized trials. Clin Trials. 2004;1(3):297–305.PubMedCrossRef
54.
go back to reference UNAIDS Data 2020. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2020. UNAIDS Data 2020. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2020.
55.
go back to reference Barnhart D, Hertzmark E, Liu E, Mungure E, Muya AN, Sando D, et al. Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam Tanzania. Contemp Clin Trials Commun 2016/10/22 ed. 2016;4:161–9.CrossRef Barnhart D, Hertzmark E, Liu E, Mungure E, Muya AN, Sando D, et al. Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam Tanzania. Contemp Clin Trials Commun 2016/10/22 ed. 2016;4:161–9.CrossRef
56.
go back to reference Miles MB, Huberman AM. Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage Publications; 1994. Miles MB, Huberman AM. Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage Publications; 1994.
57.
go back to reference Ulin PR, Robinson ET, EE T. Qualitative methods in public health: A field guide for applied research. John Wiley & Sons; 2012. Ulin PR, Robinson ET, EE T. Qualitative methods in public health: A field guide for applied research. John Wiley & Sons; 2012.
58.
go back to reference Fahey CA, Wei L, Njau PF, Shabani S, Kwilasa S, Maokola W, et al. Machine learning with routine electronic medical record data to identify people at high risk of disengagement from HIV care in Tanzania Green EP, editor. PLOS Glob Public Health. 2022;2(9):e0000720.PubMedPubMedCentralCrossRef Fahey CA, Wei L, Njau PF, Shabani S, Kwilasa S, Maokola W, et al. Machine learning with routine electronic medical record data to identify people at high risk of disengagement from HIV care in Tanzania Green EP, editor. PLOS Glob Public Health. 2022;2(9):e0000720.PubMedPubMedCentralCrossRef
59.
go back to reference Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, et al. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022;12(1):12715.ADSPubMedPubMedCentralCrossRef Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, et al. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022;12(1):12715.ADSPubMedPubMedCentralCrossRef
60.
go back to reference Stockman J, Friedman J, Sundberg J, Harris E, Bailey L. Predictive Analytics Using Machine Learning to Identify ART Clients at Health System Level at Greatest Risk of Treatment Interruption in Mozambique and Nigeria. J Acquir Immune Defic Syndr. 2022;90(2):154–60.PubMedCrossRef Stockman J, Friedman J, Sundberg J, Harris E, Bailey L. Predictive Analytics Using Machine Learning to Identify ART Clients at Health System Level at Greatest Risk of Treatment Interruption in Mozambique and Nigeria. J Acquir Immune Defic Syndr. 2022;90(2):154–60.PubMedCrossRef
61.
go back to reference Packel L, Fahey C, Kalinjila A, Mnyippembe A, Njau P, McCoy SI. Preparing a financial incentive program to improve retention in HIV care and viral suppression for scale: using an implementation science framework to evaluate an mHealth system in Tanzania. Implement Sci Commun. 2021;2(1):109.PubMedPubMedCentralCrossRef Packel L, Fahey C, Kalinjila A, Mnyippembe A, Njau P, McCoy SI. Preparing a financial incentive program to improve retention in HIV care and viral suppression for scale: using an implementation science framework to evaluate an mHealth system in Tanzania. Implement Sci Commun. 2021;2(1):109.PubMedPubMedCentralCrossRef
62.
go back to reference Pew Research Center. INTERNET CONNECTIVITY SEEN AS HAVING POSITIVE IMPACT ON LIFE IN SUB-SAHARAN AFRICA. Pew Research Center; 2018. Pew Research Center. INTERNET CONNECTIVITY SEEN AS HAVING POSITIVE IMPACT ON LIFE IN SUB-SAHARAN AFRICA. Pew Research Center; 2018.
63.
go back to reference Team TCPE. CASH PLUS: An Adolescent Livelihood, Health and Well-being Intervention as part of Tanzania’s Productive Social Safety Net Program. Florence, Italy: UNICEF, Tanzania Commission for AIDS (TACAIDS), Tanzania Social Action Fund (TASAF); Team TCPE. CASH PLUS: An Adolescent Livelihood, Health and Well-being Intervention as part of Tanzania’s Productive Social Safety Net Program. Florence, Italy: UNICEF, Tanzania Commission for AIDS (TACAIDS), Tanzania Social Action Fund (TASAF);
64.
go back to reference TIMIZA MALENGO PROGRAMME FOR AGYW: Promising Practices Report The Ulanga Experience. Tanzania Commission for AIDS (TACAIDS); 2020. TIMIZA MALENGO PROGRAMME FOR AGYW: Promising Practices Report The Ulanga Experience. Tanzania Commission for AIDS (TACAIDS); 2020.
65.
go back to reference Office P. Tanzania’s Productive Social Safety Net: What to expect and how to get it. Tanzanian Social Action Fund; 2016. Office P. Tanzania’s Productive Social Safety Net: What to expect and how to get it. Tanzanian Social Action Fund; 2016.
Metadata
Title
Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania
Authors
Jillian L. Kadota
Laura J. Packel
Matilda Mlowe
Nzovu Ulenga
Natalino Mwenda
Prosper F. Njau
William H. Dow
Jingshen Wang
Amon Sabasaba
Sandra I. McCoy
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-07960-x

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue